Dolobid and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Dolobid (diflunisal), especially for people who are male, 40-49 old, also take Neurontin, and have Metastases to bone.

The phase IV clinical study analyzes which people have Weakness when taking Dolobid. It is created by eHealthMe based on reports of 346 people who have side effects when taking Dolobid from the FDA, and is updated regularly.

What is Dolobid?

Dolobid has active ingredients of diflunisal. eHealthMe is studying from 353 Dolobid users. Check the latest studies of Dolobid.

What is Weakness?

Weakness is found to be associated with 3,639 drugs and 6,612 conditions by eHealthMe. Check the latest studies of Weakness.

On Jul, 18, 2026

346 people reported to have side effects when taking Dolobid.
Among them, 31 people (8.96%) have Weakness.

Among these 31 people:

What is the gender of people who have Weakness when taking Dolobid? *

female: 48.28 %
male: 51.72 %

What is the age of people who have Weakness when taking Dolobid? *

What are other drugs people take besides Dolobid? *

What are other side effects people have besides Weakness? *

Muscle Aches (muscle pain): 18 people, 58.06%
Back Pain: 16 people, 51.61%
Fatigue (feeling of tiredness): 16 people, 51.61%
Diarrhea: 15 people, 48.39%
Stress And Anxiety: 13 people, 41.94%
Weight Decreased: 12 people, 38.71%
Nausea (feeling of having an urge to vomit): 12 people, 38.71%
Dehydration (dryness resulting from the removal of water): 12 people, 38.71%
Insomnia (sleeplessness): 12 people, 38.71%
Swelling: 11 people, 35.48%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 10 people, 32.26%
Hereditary Neuropathic Amyloidosis (hereditary- diseases resulting from abnormal deposition of certain proteins (amyloid) in various bodily areas by problems with signals from the nerves): 4 people, 12.90%
Stress And Anxiety: 3 people, 9.68%
Pain: 2 people, 6.45%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 6.45%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 3.23%
Tooth Abscess (pus formation in tooth): 1 person, 3.23%
Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 3.23%
Muscle Spasms (muscle contraction): 1 person, 3.23%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Dolobid and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dolobid:

Dolobid (353 reports)

Weakness treatments and more:

Weakness (586,876 reports)

Browse all side effects of Dolobid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,639 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,612 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diflunisal (the active ingredients of Dolobid) and Dolobid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.